Department of Academic Cardiology, University of Hull, UK.
Int J Cardiol. 2010 Jan 7;138(1):63-9. doi: 10.1016/j.ijcard.2008.08.004. Epub 2008 Sep 11.
To identify factors associated with short term mortality in hospitalised patients with heart failure.
Hospitalisation is frequent in patients with heart failure and is associated with a high mortality.
The Euro Heart Failure survey collected data from patients with suspected heart failure. We searched this data for predictors of short term mortality.
Of 10,701 patients, 1404 (13%) died within 12 weeks of admission. On univariate analysis, increasing age, hyponatraemia, renal impairment, hyperkalaemia, anaemia, severe mitral regurgitation, severe LV systolic dysfunction(LVSD), increasing QRS and female sex carried adverse prognosis. ACEI, beta-blockers, nitrates, anti-thrombotic and lipid lowering drugs were associated with a better prognosis. On multivariable analysis the following provided independent prognostic information: increasing age (OR per SD=1.5, 95% CI 1.4-1.6), severe LVSD (1.8, 1.5-2.1), serum creatinine (1.2, 1.2-1.3), sodium (0.9, 0.8-0.9), Hb (0.9, 0.8-0.9) and treatment with ACEI (0.5, 0.5-0.6), beta-blockers (0.7, 0.6-0.8), statins (0.6, 0.5-0.7), calcium channel blockers (0.7, 0.6-0.8), warfarin (0.5, 0.4-0.6), heparin (1.7, 1.4-1.9), anti-platelet drugs (0.6, 0.5-0.6) and need for inotropes (5.5, 4.6-6.6). A simple risk score (range 0-11) identified cohorts with a 12 week mortality ranging from 2% to 44%.
Simple and readily available clinical variables and a risk score based on medical history and routine tests that all patients admitted with heart failure have, can identify patients with good, intermediate and high short term mortality.
确定与心力衰竭住院患者短期死亡率相关的因素。
心力衰竭患者经常住院,死亡率很高。
欧洲心力衰竭调查从疑似心力衰竭患者中收集数据。我们在这些数据中寻找短期死亡率的预测因素。
在 10701 名患者中,1404 名(13%)在入院后 12 周内死亡。单因素分析显示,年龄增长、低钠血症、肾功能不全、高钾血症、贫血、严重二尖瓣反流、严重左心室收缩功能障碍(LVSD)、QRS 波增宽和女性均提示预后不良。ACEI、β受体阻滞剂、硝酸盐、抗血栓和降脂药物与更好的预后相关。多变量分析显示以下因素提供了独立的预后信息:年龄增长(每标准差增加 1.5,95%CI 1.4-1.6)、严重 LVSD(1.8,1.5-2.1)、血清肌酐(1.2,1.2-1.3)、钠(0.9,0.8-0.9)、Hb(0.9,0.8-0.9)和 ACEI 治疗(0.5,0.5-0.6)、β受体阻滞剂(0.7,0.6-0.8)、他汀类药物(0.6,0.5-0.7)、钙通道阻滞剂(0.7,0.6-0.8)、华法林(0.5,0.4-0.6)、肝素(1.7,1.4-1.9)、抗血小板药物(0.6,0.5-0.6)和需要正性肌力药物(5.5,4.6-6.6)。一个简单的风险评分(范围 0-11)确定了 12 周死亡率从 2%到 44%的队列。
简单且易于获得的临床变量以及基于病史和常规检查的风险评分,所有患有心力衰竭的住院患者都有这些数据,可识别短期死亡率低、中、高的患者。